Friday 6 November 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.

Revenue: +64.0%
EPS: +525.8%
Free cash flow: +161.0%

Quarter to September 2026, against a year earlier

72.79 1.16 +1.62%

Follow CORT

Alert me

Market cap: $7.8B
P/E: 47.5×
Fwd P/E: 39.8×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	75.86	167.21	89.58	37.02	+8 more quarters Free account
P/S ratio Full definition →	12.75	11.03	5.47	4.75
P/FCF ratio Full definition →	63.13	85.69	35.04	25.49
P/Operating CF Full definition →	85.99	273.16	(251.00)	94.01
P/B ratio Full definition →	14.74	12.98	6.60	5.58
Price to Tangible BV Full definition →	14.74	12.98	6.60	5.58
EV/Sales Full definition →	12.38	10.68	5.05	4.28
EV/EBITDA Full definition →	109.69	2,382.98	0.00	78.33
EV/Operating CF Full definition →	60.23	80.85	32.27	22.94
EV/FCF Full definition →	61.30	82.95	32.35	22.97
Quick Ratio Full definition →	2.71	2.50	2.53	2.60
Current Ratio Full definition →	3.00	2.86	2.86	2.92
Net Debt/EBITDA Full definition →	(3.20)	(7.31)	6.90	2,739.77
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.60%
Debt/Equity Full definition →	0.00	0.00	0.00	0.01
Asset Turnover Full definition →	1.04	0.98	0.93	0.91
Operating CF/Net income Full definition →	1.15	0.80	0.54	1.61
Capex/Depreciation Full definition →	(0.69)	(2.93)	(0.34)	0.01
Research and Development Expense of Revenue Full definition →	16.66%	21.04%	40.18%	32.09%
Selling, General and Administrative Expense of Revenue Full definition →	48.30%	61.25%	88.15%	64.43%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	8.65%	11.48%	13.97%	10.27%
Graham Net Nets Full definition →	0.03	0.03	0.06	0.08
Graham Number Full definition →	16.35	8.85	7.86	11.49
Earnings Yield Full definition →	1.32%	0.60%	1.12%	2.70%
Free Cash Flow Yield Full definition →	1.58%	1.17%	2.85%	3.92%
Revenue per Share Full definition →	3.19	2.43	1.58	1.95
Operating CF per Share Full definition →	1.34	0.32	(0.16)	0.37
Capex per Share Full definition →	(0.01)	(0.02)	0.00	0.00
Free Cash Flow per Share Full definition →	1.33	0.29	(0.16)	0.37
Cash per Share Full definition →	3.48	2.92	3.24	3.58
Shareholders Equity per Share Full definition →	7.82	6.70	6.11	6.24
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	7.82	6.70	6.11	6.24
Free Cash Flow Full definition →	142.18	31.02	(16.97)	38.40
Working Capital Full definition →	356.20	285.87	276.85	319.38
Capital Expenditures Full definition →	(0.71)	(2.53)	(0.20)	(0.05)
Net Current Asset Value Full definition →	333.59	256.75	249.14	296.62
EV/EBIT Full definition →	107.58	1,384.77	0.00	72.71
Capex to Sales Full definition →	0.00	0.01	0.00	0.00
Price to Operating Income Full definition →	110.78	1,430.53	0.00	80.68
Other line items
Average Receivables Full definition →	90.35	70.74	50.45	56.88
Average Payables Full definition →	28.19	19.22	30.63	27.91
Average Inventory Full definition →	12.13	12.73	13.63	12.64
Average Assets Full definition →	928.82	845.21	830.67	838.60
Average Common Equity Full definition →	732.82	670.78	660.64	663.70

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly